HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity
Science Advances · 2025
DOI: 10.1126/sciadv.adx7485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Sandra Dehn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: HIV-1, CD4-Positive T-Lymphocytes, HIV Infections, Antigens, CD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
HIV-1 evades immune responses by modulating plasma membrane receptors. Using a flow cytometry–based screening, we profiled 332 surface receptors on HIV-1–infected primary CD4 + T cells and identified 23 down-regulated receptors, including known targets such as CD4, MHCI, CCR7, and CD62L. CD96, an inhibitory natural killer (NK) cell receptor poorly studied in human CD4 + T cells, was markedly down-regulated. This modulation, mediated by the viral proteins Nef and Vpu, surpassed that of other NK-associated receptors such as CD155 and NTB-A and is conserved across lentiviruses. CD96 Hi CD4 + T cells exhibited a proinflammatory T H 1/T H 17 phenotype characterized by IFN-γ and IL-17 secretion and displayed impaired migration in vivo. Furthermore, CD96 ligation enhanced IFN-γ release upon viral peptide stimulation and promoted the secretion of T H 1/T H 17-associated cytokines. Our findings suggest that CD96 regulates antiviral immune responses and maintains proinflammatory properties in CD4 + T cells. Thus, its down-regulation represents a previously unknown HIV-1 immune evasion strategy, with implications for exploiting CD96 as immunotherapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
- Institute of Virology, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Neuherberg, Germany.
- Department of Oncology, Hematology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
- Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
- Department of Pediatric Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany.
ORCID-Profile: Sandra Dehn, Johanna Leyens, Tabea Kaiser, Dinah Heiligensetzer, Baubak Bajoghli, Michael Schindler
Zitieren
APA
Dehn, S., Burkhard, R., Leyens, J., Kaiser, T., Brandimarte, S., Heiligensetzer, D., Koppensteiner, H., Bajoghli, B., Hailfinger, S., Schilbach, K., & Schindler, M. (2025). HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity. Science Advances. https://doi.org/10.1126/sciadv.adx7485
Vancouver
Dehn S, Burkhard R, Leyens J, Kaiser T, Brandimarte S, Heiligensetzer D, et al. HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity. Science Advances. 2025. doi:10.1126/sciadv.adx7485
BibTeX
@article{Dehn2025,
author = {Dehn, Sandra and Burkhard, Rabea and Leyens, Johanna and Kaiser, Tabea and Brandimarte, Simone and Heiligensetzer, Dinah and Koppensteiner, Herwig and Bajoghli, Baubak and Hailfinger, Stephan and Schilbach, Karin and Schindler, Michael},
title = {HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx7485}
}
EUVIMED